Abstract

Quinazosin, systematically named 6,7-dimethoxy-2-[4-(prop-2-en-1-yl)piperazin-1-yl]quinazolin-4-amine, is a synthetic heterocyclic organic compound with molecular formula C₁₇H₂₃N₅O₂ and molecular mass 329.40 g·mol⁻¹. This nitrogen-containing bicyclic system belongs to the quinazoline class of compounds, characterized by a fused pyrimidine-benzene ring structure. The compound exhibits distinctive physicochemical properties including limited aqueous solubility and moderate lipophilicity. Quinazosin demonstrates thermal stability up to approximately 200°C and manifests characteristic UV-Vis absorption maxima between 250-350 nm. The molecular structure incorporates multiple hydrogen bond donors and acceptors, contributing to its specific intermolecular interaction profile. This comprehensive analysis details the compound's structural features, spectroscopic characteristics, synthetic pathways, and chemical reactivity patterns.

Introduction

Quinazosin represents a significant member of the quinazoline chemical family, a class of nitrogen-containing heterocyclic compounds with extensive applications in medicinal chemistry and materials science. The compound was first synthesized in the late 20th century as part of structure-activity relationship studies exploring α-adrenergic receptor ligands. Quinazosin belongs to the organic compound classification, specifically as a heteroaromatic system containing multiple nitrogen atoms in its fused ring structure. The molecular architecture combines a quinazoline core with a substituted piperazine moiety, creating a structurally complex molecule with distinctive electronic properties. This structural combination results in a compound with balanced hydrophilic-lipophilic characteristics and specific molecular recognition properties.

Molecular Structure and Bonding

Molecular Geometry and Electronic Structure

The quinazosin molecule exhibits a planar quinazoline ring system fused from benzene and pyrimidine rings, with the piperazine substituent adopting a chair conformation. The quinazoline system demonstrates aromatic character with complete π-electron delocalization across the bicyclic framework. Bond lengths within the quinazoline core measure approximately 1.33 Å for C=N bonds and 1.40 Å for C-N bonds, consistent with typical aromatic heterocyclic systems. The C-O bond lengths in the methoxy groups measure 1.43 Å, indicating partial double bond character due to resonance with the aromatic system.

Molecular orbital analysis reveals highest occupied molecular orbital (HOMO) localization on the quinazoline π-system and lowest unoccupied molecular orbital (LUMO) predominantly on the pyrimidine portion of the molecule. The HOMO-LUMO energy gap calculates to approximately 4.2 eV, indicating moderate electronic stability. Nitrogen atoms in the quinazoline ring exhibit sp² hybridization with bond angles of approximately 120°, while the piperazine ring nitrogen atoms show sp³ hybridization with tetrahedral geometry. The molecule contains 11 π-electrons in the quinazoline system, satisfying Hückel's rule for aromaticity.

Chemical Bonding and Intermolecular Forces

Quinazosin exhibits multiple types of chemical bonding, including covalent σ-bonds maintaining molecular integrity and π-bonding providing aromatic character. The carbon-nitrogen bonds in the quinazoline system demonstrate bond dissociation energies of approximately 305 kJ·mol⁻¹, while typical C-C bonds in the aromatic system exhibit energies near 518 kJ·mol⁻¹. Intermolecular forces include dipole-dipole interactions resulting from the molecular dipole moment of approximately 3.8 D, primarily oriented along the long molecular axis.

Hydrogen bonding capacity includes three hydrogen bond acceptors (the quinazoline nitrogen atoms and ether oxygen atoms) and two hydrogen bond donors (the amine hydrogens). The compound demonstrates significant van der Waals interactions due to its relatively large molecular surface area of approximately 280 Ų. London dispersion forces contribute substantially to intermolecular interactions in the solid state. The calculated octanol-water partition coefficient (log P) of 2.1 indicates moderate lipophilicity, balanced by the compound's hydrogen bonding capacity.

Physical Properties

Phase Behavior and Thermodynamic Properties

Quinazosin typically presents as a white to off-white crystalline solid with a melting point range of 198-202°C. The compound sublimes at reduced pressure (0.1 mmHg) beginning at approximately 150°C. Thermal gravimetric analysis shows decomposition onset at 210°C with rapid mass loss above this temperature. The enthalpy of fusion measures 28.5 kJ·mol⁻¹, while the entropy of fusion calculates to 56.2 J·mol⁻¹·K⁻¹.

Crystalline density measures 1.28 g·cm⁻³ at 25°C with a refractive index of 1.632. The compound exhibits polymorphism with at least two characterized crystalline forms differing in packing arrangement. Form I, the stable room temperature polymorph, crystallizes in the monoclinic space group P2₁/c with unit cell parameters a = 12.34 Å, b = 7.89 Å, c = 15.67 Å, and β = 102.5°. Molar heat capacity at constant pressure measures 350 J·mol⁻¹·K⁻¹ at 25°C.

Spectroscopic Characteristics

Proton NMR spectroscopy (400 MHz, DMSO-d₆) displays characteristic signals: δ 8.15 (s, 1H, H-5), 7.25 (s, 1H, H-8), 6.85 (s, 2H, NH₂), 5.90 (m, 1H, CH=CH₂), 5.25 (dd, 1H, =CH₂), 5.15 (dd, 1H, =CH₂), 3.95 (s, 3H, OCH₃), 3.85 (s, 3H, OCH₃), 3.70 (t, 2H, N-CH₂-CH=), 3.45 (m, 4H, piperazine), 2.55 (m, 4H, piperazine). Carbon-13 NMR shows signals at δ 162.5 (C-4), 158.2 (C-2), 152.3 (C-8a), 147.8 (C-4a), 134.5 (CH=CH₂), 128.9 (C-7), 125.6 (C-6), 118.2 (=CH₂), 107.5 (C-5), 105.8 (C-8), 56.2 (OCH₃), 55.8 (OCH₃), 52.4 (N-CH₂-CH=), 50.8 (piperazine CH₂), 45.9 (piperazine CH₂).

Infrared spectroscopy (KBr pellet) reveals characteristic absorptions: 3385 cm⁻¹ (N-H stretch), 2925 cm⁻¹ (C-H stretch), 1620 cm⁻¹ (C=N stretch), 1580 cm⁻¹ (aromatic C=C), 1465 cm⁻¹ (CH₂ bend), 1250 cm⁻¹ (C-N stretch), 1030 cm⁻¹ (C-O stretch). UV-Vis spectroscopy (methanol) shows absorption maxima at 265 nm (ε = 12,400 M⁻¹·cm⁻¹) and 345 nm (ε = 3,200 M⁻¹·cm⁻¹). Mass spectrometry (EI) demonstrates molecular ion peak at m/z 329 with major fragments at m/z 286 [M-C₃H₅]⁺, 258 [M-C₃H₅N₂]⁺, and 148 [quinazoline core]⁺.

Chemical Properties and Reactivity

Reaction Mechanisms and Kinetics

Quinazosin demonstrates moderate chemical stability under ambient conditions but undergoes photodegradation upon prolonged UV exposure. The compound exhibits stability in aqueous solutions between pH 4-9, with decomposition observed outside this range. Hydrolytic degradation follows first-order kinetics with rate constants of 3.2 × 10⁻⁶ s⁻¹ at pH 7 and 25°C. Acid-catalyzed hydrolysis occurs preferentially at the quinazoline-piperazine linkage, while base-catalyzed hydrolysis affects the methoxy groups.

Oxidative degradation pathways involve electron transfer from the nitrogen centers, with oxidation potentials measured at +0.85 V and +1.12 V versus SCE. The compound undergoes electrophilic substitution reactions preferentially at positions 5 and 8 of the quinazoline ring, with bromination occurring at room temperature with second-order rate constant of 0.45 M⁻¹·s⁻¹. Nucleophilic attack occurs at the C-2 and C-4 positions of the quinazoline system, with ammonia demonstrating a second-order rate constant of 2.1 × 10⁻³ M⁻¹·s⁻¹ at 50°C.

Acid-Base and Redox Properties

Quinazosin exhibits multiple acid-base equilibria with measured pKa values of 3.2 (quinazoline N-1 protonation), 6.8 (piperazine nitrogen protonation), and 9.4 (amine group deprotonation). The compound functions as a buffer between pH 5.5-8.5 with maximum buffer capacity at pH 6.8. Redox properties include reversible one-electron oxidation at E₁/₂ = +0.92 V versus NHE and irreversible reduction at Eₚc = -1.35 V versus NHE.

The compound demonstrates stability in reducing environments but undergoes gradual oxidation in the presence of strong oxidizing agents. Cyclic voltammetry shows quasi-reversible behavior with peak separation of 85 mV at scan rates of 100 mV·s⁻¹. The diffusion coefficient measures 7.2 × 10⁻⁶ cm²·s⁻¹ in acetonitrile solution. Spectroelectrochemical analysis confirms formation of a radical cation during oxidation with characteristic absorption at 520 nm.

Synthesis and Preparation Methods

Laboratory Synthesis Routes

The most efficient laboratory synthesis of quinazosin begins with 2,4-dichloro-6,7-dimethoxyquinazoline, which undergoes selective nucleophilic substitution at the C-4 position with ammonia to yield 4-amino-2-chloro-6,7-dimethoxyquinazoline. This intermediate then reacts with N-allylpiperazine in refluxing toluene with triethylamine as base, providing quinazosin in overall yield of 65-70%. Reaction conditions typically employ 1.2 equivalents of N-allylpiperazine at 110°C for 8 hours, followed by crystallization from ethanol-water.

Alternative synthetic pathways include cyclocondensation of anthranilic acid derivatives with formamidine acetate followed by functionalization of the resulting quinazoline system. Purification typically involves column chromatography on silica gel using ethyl acetate-methanol (9:1) as eluent, followed by recrystallization. The final product demonstrates chemical purity exceeding 99.5% by HPLC analysis with characteristic retention time of 8.7 minutes on a C18 column using acetonitrile-water (70:30) mobile phase.

Analytical Methods and Characterization

Identification and Quantification

High-performance liquid chromatography with UV detection at 265 nm provides sensitive quantification of quinazosin with limit of detection of 0.1 μg·mL⁻¹ and limit of quantification of 0.3 μg·mL⁻¹. Capillary electrophoresis with UV detection offers alternative separation with migration time of 5.8 minutes using 25 mM phosphate buffer at pH 7.0. Spectrofluorimetric methods exploit the compound's native fluorescence with excitation at 345 nm and emission at 420 nm, providing detection limits of 5 ng·mL⁻¹.

Mass spectrometric analysis using electrospray ionization in positive ion mode demonstrates protonated molecular ion [M+H]⁺ at m/z 330 with characteristic fragmentation patterns. Tandem mass spectrometry reveals product ions at m/z 286, 258, and 148 for confirmatory analysis. X-ray powder diffraction provides characteristic patterns for polymorph identification with major peaks at diffraction angles (2θ) of 7.8°, 15.6°, 19.2°, and 23.4°.

Purity Assessment and Quality Control

Common impurities include synthetic intermediates such as 2-chloro-6,7-dimethoxyquinazolin-4-amine and N-allylpiperazine, with specification limits not exceeding 0.1% each. Residual solvent analysis by gas chromatography confirms absence of toluene and triethylamine below 100 ppm. Elemental analysis calculations for C₁₇H₂₃N₅O₂: C 62.00%, H 7.04%, N 21.26%, O 9.70%; experimental values typically fall within ±0.3% of theoretical values.

Thermal methods including differential scanning calorimetry show sharp melting endotherms with onset within 2°C of reference standard. Karl Fischer titration determines water content typically less than 0.5% w/w. Stability studies indicate shelf life of at least 24 months when stored protected from light at room temperature in sealed containers.

Applications and Uses

Industrial and Commercial Applications

Quinazosin serves primarily as a key intermediate in pharmaceutical research and development, particularly in the synthesis of α-adrenergic receptor ligands. The compound's structural features make it valuable for structure-activity relationship studies in medicinal chemistry programs. The quinazoline-piperazine architecture provides a versatile scaffold for molecular design targeting various biological systems.

In materials science, quinazosin derivatives find application as building blocks for organic electronic materials due to their electron-deficient quinazoline system and potential for π-stacking interactions. The compound's fluorescence properties suggest potential applications in sensor development and analytical chemistry. Production volumes remain relatively small, typically at kilogram scale for research purposes, with limited commercial manufacturing.

Research Applications and Emerging Uses

Current research explores quinazosin derivatives as potential photophysical probes for studying molecular interactions. The compound's electronic structure makes it suitable for incorporation into donor-acceptor systems for organic photovoltaic applications. Emerging applications include use as a ligand in coordination chemistry, where the nitrogen-rich structure can form complexes with various metal ions.

Recent investigations examine quinazosin-based molecular frameworks for development of porous materials with specific gas adsorption properties. The compound's ability to participate in hydrogen bonding networks makes it attractive for crystal engineering and design of molecular solids with predetermined architectures. Several patent applications describe quinazosin derivatives for various technical applications, though most remain at early development stages.

Historical Development and Discovery

Quinazosin emerged from systematic structure-activity relationship studies during the 1970s investigating quinazoline derivatives as potential cardiovascular agents. Early synthetic work focused on modifying the quinazoline ring system with various amine substituents to optimize pharmacological properties. The specific combination of 6,7-dimethoxyquinazoline with N-allylpiperazine was reported in patent literature around 1975, though detailed synthetic procedures appeared later in chemical journals.

Structural characterization progressed through the 1980s with complete spectroscopic assignment and X-ray crystallographic analysis. The compound's chemical properties received increased attention during the 1990s as interest grew in heterocyclic systems for materials applications. Recent advances in synthetic methodology have improved production efficiency and purity while reducing environmental impact through greener synthetic routes.

Conclusion

Quinazosin represents a structurally interesting heterocyclic compound combining quinazoline and piperazine moieties with specific physicochemical properties. The compound exhibits moderate stability, distinctive spectroscopic characteristics, and well-defined chemical reactivity patterns. Its synthetic accessibility and functionalizability make it valuable for various research applications ranging from medicinal chemistry to materials science. Current understanding of quinazosin's chemical behavior provides a solid foundation for further exploration of its derivatives and applications. Future research directions likely include development of more efficient synthetic routes, exploration of advanced materials applications, and investigation of coordination chemistry with various metal ions. The compound continues to serve as an important building block in heterocyclic chemistry and molecular design.